Information Provided By: 
Fly News Breaks for September 5, 2019
GBT
Sep 5, 2019 | 15:43 EDT
After meeting up with management at Global Blood Therapeutics following the company's announcement regarding the FDA acceptance of the voxelotor NDA, SunTrust analyst Joon Lee said he thinks a bid for the company is "quite possible" and he would not be surprised if a takeover offer comes before the PDUFA target action date of February 26, 2020. He maintains a Buy rating on Global Blood shares and has a $90 price target on the stock, which is up $6.05, or 13%, to $53.54 heading into the close.
News For GBT From the Last 2 Days
There are no results for your query GBT
